4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
EMPA-REG OUTCOME - Empagliflozin ... DECLARE-TIMI 58 - Dapagliflozin ... CREDENCE - Canagliflozin ... DAPA-CKD - Dapagliflozin ... DAPA-HF - Dapagliflozin
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
treatment of type II diabetes ... triple therapy: canagliflozin ... (Invokana®), dapagliflozin ... , #dapagliflozin ... , #empagliflozin
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... Medications ... • SGLT2i (Dapagliflozin ... sarahthelyon #Diabetes ... #Medications #pharmacology
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
Dapagliflozin in ... those who received dapagliflozin ... or absence of diabetes ... Kosalan Akilan #Dapagliflozin ... #ebm